KBAB:NSD-KraneShares 2x Long BABA Daily ETF (USD)

ETF | Others |

Last Closing

USD 15.3003

Change

0.00 (0.00)%

Market Cap

N/A

Volume

4.71K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

-0.10 (-0.17%)

USD 65.59B
QQQM Invesco NASDAQ 100 ETF

+1.68 (+0.79%)

USD 46.74B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.40 (-0.76%)

USD 25.59B
ACWI iShares MSCI ACWI ETF

+0.92 (+0.74%)

USD 21.43B
CGABL The Carlyle Group Inc. 4.625% ..

-0.07 (-0.41%)

USD 16.14B
TSLL Direxion Shares ETF Trust - Di..

-0.27 (-1.81%)

USD 6.20B
TBIL Rbb Fund Inc - Us Treasury 3 M..

-0.16 (-0.32%)

USD 5.83B
ETHA iShares Ethereum Trust ETF

-0.31 (-1.59%)

USD 3.58B
NVDL GraniteShares 1.5x Long NVDA D..

+2.01 (+3.86%)

USD 3.52B
MAGS Roundhill Magnificent Seven ET..

+0.38 (+0.73%)

USD 2.32B

ETFs Containing KBAB

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike